{"entity":{"type":"insider","cik":"0001639078","url":"/insider/0001639078","json_url":"/insider/0001639078.json","name":"SIMARD JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":7,"first":"2021-07-19","last":"2022-02-15","span_basis":"filed_date"},"name_variants":[{"name":"SIMARD JOHN","source":"filing","n_filings":7,"first_seen":"2021-07-19","last_seen":"2022-02-15"}],"transactions":[{"id":6977130,"accession":"0001209191-22-009745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-009745","line_url":"/filing/0001209191-22-009745#line-2","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":13.0683,"price_display":"13.07","price_state":"stated","total_value":431253.9,"total_display":"431,253.90","total_whole":"431,254","shares_owned_after":3823166.0,"shares_owned_after_display":"3,823,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2022-02-15","scope":"insider"},{"id":6977127,"accession":"0001209191-22-009745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-009745","line_url":"/filing/0001209191-22-009745#line-1","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":13.3218,"price_display":"13.32","price_state":"stated","total_value":226470.6,"total_display":"226,470.60","total_whole":"226,471","shares_owned_after":3856166.0,"shares_owned_after_display":"3,856,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2022-02-15","scope":"insider"},{"id":4385815,"accession":"0001209191-21-060523","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-060523","line_url":"/filing/0001209191-21-060523#line-4","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21125.0,"shares_display":"21,125","price_per_share":12.9005,"price_display":"12.90","price_state":"stated","total_value":272523.0625,"total_display":"272,523.06","total_whole":"272,523","shares_owned_after":3873166.0,"shares_owned_after_display":"3,873,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-15","scope":"insider"},{"id":4385811,"accession":"0001209191-21-060523","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-060523","line_url":"/filing/0001209191-21-060523#line-3","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10875.0,"shares_display":"10,875","price_per_share":12.83,"price_display":"12.83","price_state":"stated","total_value":139526.25,"total_display":"139,526.25","total_whole":"139,526","shares_owned_after":3962452.0,"shares_owned_after_display":"3,962,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-15","scope":"insider"},{"id":4385801,"accession":"0001209191-21-060523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060523","line_url":"/filing/0001209191-21-060523#line-2","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":12.7744,"price_display":"12.77","price_state":"stated","total_value":229939.2,"total_display":"229,939.20","total_whole":"229,939","shares_owned_after":3973166.0,"shares_owned_after_display":"3,973,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-15","scope":"insider"},{"id":4385795,"accession":"0001209191-21-060523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060523","line_url":"/filing/0001209191-21-060523#line-1","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39286.0,"shares_display":"39,286","price_per_share":12.45,"price_display":"12.45","price_state":"stated","total_value":489110.7,"total_display":"489,110.70","total_whole":"489,111","shares_owned_after":3923166.0,"shares_owned_after_display":"3,923,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-07","filed_date":"2021-10-15","scope":"insider"},{"id":5113115,"accession":"0001209191-21-059849","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-059849","line_url":"/filing/0001209191-21-059849#line-3","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10714.0,"shares_display":"10,714","price_per_share":12.5312,"price_display":"12.53","price_state":"stated","total_value":134259.2768,"total_display":"134,259.28","total_whole":"134,259","shares_owned_after":3962452.0,"shares_owned_after_display":"3,962,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-06","filed_date":"2021-10-06","scope":"insider"},{"id":5113110,"accession":"0001209191-21-059849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059849","line_url":"/filing/0001209191-21-059849#line-2","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14218.0,"shares_display":"14,218","price_per_share":12.6641,"price_display":"12.66","price_state":"stated","total_value":180058.1738,"total_display":"180,058.17","total_whole":"180,058","shares_owned_after":3973166.0,"shares_owned_after_display":"3,973,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-06","scope":"insider"},{"id":5113104,"accession":"0001209191-21-059849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059849","line_url":"/filing/0001209191-21-059849#line-1","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23681.0,"shares_display":"23,681","price_per_share":13.0849,"price_display":"13.08","price_state":"stated","total_value":309863.5169,"total_display":"309,863.52","total_whole":"309,864","shares_owned_after":3987384.0,"shares_owned_after_display":"3,987,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-06","scope":"insider"},{"id":4793485,"accession":"0001209191-21-058475","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-058475","line_url":"/filing/0001209191-21-058475#line-4","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19684.0,"shares_display":"19,684","price_per_share":13.2335,"price_display":"13.23","price_state":"stated","total_value":260488.214,"total_display":"260,488.21","total_whole":"260,488","shares_owned_after":4011065.0,"shares_owned_after_display":"4,011,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-01","scope":"insider"},{"id":4793481,"accession":"0001209191-21-058475","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-058475","line_url":"/filing/0001209191-21-058475#line-3","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18558.0,"shares_display":"18,558","price_per_share":13.0652,"price_display":"13.07","price_state":"stated","total_value":242463.9816,"total_display":"242,463.98","total_whole":"242,464","shares_owned_after":4030749.0,"shares_owned_after_display":"4,030,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-30","filed_date":"2021-10-01","scope":"insider"},{"id":4793476,"accession":"0001209191-21-058475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-058475","line_url":"/filing/0001209191-21-058475#line-2","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16396.0,"shares_display":"16,396","price_per_share":13.4058,"price_display":"13.41","price_state":"stated","total_value":219801.4968,"total_display":"219,801.50","total_whole":"219,801","shares_owned_after":4049307.0,"shares_owned_after_display":"4,049,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-10-01","scope":"insider"},{"id":4793472,"accession":"0001209191-21-058475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-058475","line_url":"/filing/0001209191-21-058475#line-1","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6263.0,"shares_display":"6,263","price_per_share":14.2685,"price_display":"14.27","price_state":"stated","total_value":89363.6155,"total_display":"89,363.62","total_whole":"89,364","shares_owned_after":4065703.0,"shares_owned_after_display":"4,065,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-28","filed_date":"2021-10-01","scope":"insider"},{"id":4104484,"accession":"0001209191-21-057877","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-057877","line_url":"/filing/0001209191-21-057877#line-3","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29890.0,"shares_display":"29,890","price_per_share":14.814,"price_display":"14.81","price_state":"stated","total_value":442790.46,"total_display":"442,790.46","total_whole":"442,790","shares_owned_after":4071966.0,"shares_owned_after_display":"4,071,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-28","scope":"insider"},{"id":4104482,"accession":"0001209191-21-057877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057877","line_url":"/filing/0001209191-21-057877#line-2","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11418.0,"shares_display":"11,418","price_per_share":14.4867,"price_display":"14.49","price_state":"stated","total_value":165409.1406,"total_display":"165,409.14","total_whole":"165,409","shares_owned_after":4101856.0,"shares_owned_after_display":"4,101,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-24","filed_date":"2021-09-28","scope":"insider"},{"id":4104479,"accession":"0001209191-21-057877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057877","line_url":"/filing/0001209191-21-057877#line-1","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9892.0,"shares_display":"9,892","price_per_share":14.6805,"price_display":"14.68","price_state":"stated","total_value":145219.506,"total_display":"145,219.51","total_whole":"145,220","shares_owned_after":4113274.0,"shares_owned_after_display":"4,113,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-28","scope":"insider"},{"id":5336932,"accession":"0001209191-21-057295","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-057295","line_url":"/filing/0001209191-21-057295#line-3","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19669.0,"shares_display":"19,669","price_per_share":15.1384,"price_display":"15.14","price_state":"stated","total_value":297757.1896,"total_display":"297,757.19","total_whole":"297,757","shares_owned_after":4123166.0,"shares_owned_after_display":"4,123,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-22","filed_date":"2021-09-22","scope":"insider"},{"id":5336928,"accession":"0001209191-21-057295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057295","line_url":"/filing/0001209191-21-057295#line-2","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16860.0,"shares_display":"16,860","price_per_share":15.238,"price_display":"15.24","price_state":"stated","total_value":256912.68,"total_display":"256,912.68","total_whole":"256,913","shares_owned_after":4142835.0,"shares_owned_after_display":"4,142,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":5336921,"accession":"0001209191-21-057295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057295","line_url":"/filing/0001209191-21-057295#line-1","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13471.0,"shares_display":"13,471","price_per_share":15.063,"price_display":"15.06","price_state":"stated","total_value":202913.673,"total_display":"202,913.67","total_whole":"202,914","shares_owned_after":4159695.0,"shares_owned_after_display":"4,159,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"},{"id":4894745,"accession":"0001209191-21-047105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-047105","line_url":"/filing/0001209191-21-047105#line-1","is_derivative":false,"issuer_cik":"0001626878","issuer_name":"XBiotech Inc.","issuer_ticker":"XBIT","issuer_name_source":null,"issuer_url":"/issuer/0001626878","owner_cik":"0001639078","owner_name":"SIMARD JOHN","owner_display_name":"SIMARD JOHN","owner_url":"/insider/0001639078","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":18.147,"price_display":"18.15","price_state":"stated","total_value":907350.0,"total_display":"907,350.00","total_whole":"907,350","shares_owned_after":4173166.0,"shares_owned_after_display":"4,173,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001626878","name":"XBiotech Inc.","url":"/issuer/0001626878","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":7,"first_seen":"2021-07-19","last_seen":"2022-02-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001639078","retrieved_at":"2026-08-27T21:52:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}